Novartis Pharma B.V.

Location

Noord-Holland

Founded

1948-02-10

Risk Signals

21159 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Novartis Pharma B.V.

Live alerts from global media, monitored by Business Radar

FDA Lifts 3-Year Block On Study Of Marijuana Benefits For PTSD In Vets

2024-11-22 (kffhealthnews.org)

FDA Lifts 3-Year Block On Study Of Marijuana Benefits For PTSD In Vets

Meanwhile, cannabis progress could stop under the Trump administration; a labeling issue prompts a recall of the popular drug Clonazepam; Novartis acquires Kate Therapeutics; and more.

Read more
FDA Lifts 3-Year Block On Study Of Marijuana Benefits For PTSD In Vets

2024-11-22 (kffhealthnews.org)

FDA Lifts 3-Year Block On Study Of Marijuana Benefits For PTSD In Vets

Meanwhile, cannabis progress could stop under the Trump administration; a labeling issue prompts a recall of the popular drug Clonazepam; Novartis acquires Kate Therapeutics; and more.

Read more
Novartis Launches Another Recall of Comtan over Nitrosamine Impurities

2024-10-09 (jiho.jp)

Novartis Launches Another Recall of Comtan over Nitrosamine Impurities

Novartis Pharma on October 8 initiated a voluntary recall of certain batches of its peripheral catec…

Read more
Novartis Launches Another Recall of Comtan over Nitrosamine Impurities

2024-10-09 (jiho.jp)

Novartis Launches Another Recall of Comtan over Nitrosamine Impurities

Novartis Pharma on October 8 initiated a voluntary recall of certain batches of its peripheral catec…

Read more
Closure failure behind Novartis OTC recall

2024-05-07 (packagingdigest.com)

Closure failure behind Novartis OTC recall

Novartis Consumer Health has announced that it is voluntarily recalling certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactu

Read more
Closure failure behind Novartis OTC recall

2024-05-07 (packagingdigest.com)

Closure failure behind Novartis OTC recall

Novartis Consumer Health has announced that it is voluntarily recalling certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactu

Read more
Novartis recalls Adakveo in the UK

2024-02-21 (thepharmaletter.com)

Novartis recalls Adakveo in the UK

Novartis recalls Adakveo in the UK

Read more
Novartis recalls Adakveo in the UK

2024-02-21 (thepharmaletter.com)

Novartis recalls Adakveo in the UK

Novartis recalls Adakveo in the UK

Read more
Novartis denied the allegations: We did not withdraw from Turkey

2024-01-27 (dokuzeylul.com)

Novartis denied the allegations: We did not withdraw from Turkey

Novartis emphasized that they are working to prevent patients and their relatives from suffering, and stated that they will continue their activities in the country and contribute to healthcare services. Novartis' statement stated that the company did not withdraw from Turkey and continued its activities in the country.

Read more
The famous pharmaceutical company denied the claim that it would withdraw from Turkey

2024-01-26 (ekonomist.com.tr)

The famous pharmaceutical company denied the claim that it would withdraw from Turkey

Novartis stated that all information and comments regarding their withdrawal from Turkey are unfounded.

Read more
Novartis: We did not withdraw from Turkey

2024-01-26 (gazeteduvar.com.tr)

Novartis: We did not withdraw from Turkey

Novartis made a statement regarding the allegations that they withdrew from Turkey: "We would like to inform the public that we will continue to contribute to the growth and development of our country."

Read more
Sandoz strengthens in the United States with the purchase of a biosimilar

2024-01-22 (rtn.ch)

Sandoz strengthens in the United States with the purchase of a biosimilar

The pharmaceutical group Sandoz has announced the purchase of the drug Cimerli, a biosimilar of the product Lucentis, from the company Coherus, to strengthen its position in the ophthalmology sector in the United States.

Read more

Never miss a headline about Novartis Pharma B.V.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages